Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

TomoTherapy to Present at Three Upcoming Investment Conferences

Thu. June 04, 2009; Posted: 09:00 AM
Stocks RSS
MADISON, Wis., Jun 04, 2009 (BUSINESS WIRE) -- TOMO | Quote | Chart | News | PowerRating -- --Needham Life Sciences Conference on June 10

--William Blair Growth Stock Conference on June 10

TomoTherapy Incorporated (NASDAQ: TOMO | Quote | Chart | News | PowerRating) today announced that management will participate in three investment community conferences in early June.

On Tuesday, June 9, 2009, Gustavo Olivera, Ph.D., vice president of research, and Shawn Guse, vice president of international operations, will present at the Lazard Capital Markets Radiation Oncology Conference at 9:15 a.m. EDT. The conference is being held at Le Parker Meridien hotel in New York City, NY.

Olivera and Guse will also present at the 8th Annual Needham Life Sciences Conference on Wednesday, June 10, 2009 at 9:00 a.m. EDT. The conference takes place at the New York Palace hotel in New York City, NY.

On Wednesday, June 10, 2009, Steve Hathaway, CFO, and Del Coufal, vice president of marketing, will present at William Blair's 29th Annual Growth Stock Conference at 2:40 p.m. CDT. The conference is being held at the Four Seasons Hotel in Chicago, Ill.

Live Webcasts of the Needham and William Blair conference presentations will be available on the investor relations page of TomoTherapy.com. For those who are unable to listen to the live presentations, archives of the Webcasts will be available on the company's site for 30 days following the presentation. The Lazard Capital Markets presentation is not being Webcast.

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, markets and sells the TomoTherapy(R) Hi-Art(R) treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi-Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

(C)2009 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and Hi-Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.

SOURCE: TomoTherapy Incorporated

TomoTherapy Incorporated 
Investor Contact: 
Stephen C. Hathaway 
Chief Financial Officer 
608.824.2800 
shathaway@tomotherapy.com 
or 
Media Contact: 
Kevin O'Malley 
Manager, Corporate Communications 
608.824.3384 
komalley@tomotherapy.com
For full details for TOMO click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [TOMO]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.